First we confirmed the previous report by Ohgaki [23] that the phosphoinositide 3-kinase (PI3K) pathway is often constitutively active in GB as a result of mutations and loss of a tumor suppressor, PTEN, compared with the other cancer cell lines (Additional file 1). This evidence concerns the gene PTEN and cancer.